Skip to main content
Andreas Klein, MD, Hematology, Boston, MA

AndreasKKleinMD

Hematology Boston, MA

Hematologic Oncology

Wellforce

Dr. Klein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Klein's full profile

Already have an account?

  • Office

    750 Washington St
    Boston, MA 02111
    Phone+1 617-636-5000
    Fax+1 617-636-6204

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1998 - 2001
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 1995 - 1998
  • Yale School of Medicine
    Yale School of MedicineClass of 1995

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • NC State Medical License
    NC State Medical License 1998 - 2001
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014, 2016-2017, 2019-2022
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinicopathologic Characteristics of Secondary Squamous Cell Carcinoma of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematolo...  
    Kenneth B Miller, Kellie A Sprague, Chakra P Chaulagain, Esha Kaul, Andreas K Klein, Janet Cowan, Nature

Abstracts/Posters

  • A Phase I/II Trial of Brentuximab Vedotin (BV) Plus Rituximab (R) As Frontline Therapy for Patients with Immunosuppression-Associated CD30+ and/or EBV+ Lymphomas
    Andreas Klein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Andreas Klein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia Therapy
    Andreas Klein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Center for Health Literacy Research + Practice
    Center for Health Literacy Research + PracticeAugust 23rd, 2024
  • Development and Clinical Application of CD19xCD3 and CD20xCD3 Bispecific Antibodies
    Development and Clinical Application of CD19xCD3 and CD20xCD3 Bispecific AntibodiesJanuary 17th, 2022
  • Old Idea, New Desperation: Can Plasma from Recovered Patients Help Those Now Battling COVID-19?
    Old Idea, New Desperation: Can Plasma from Recovered Patients Help Those Now Battling COVID-19?May 22nd, 2020
  • Join now to see all

Committees

  • Chair, Tufts Health Sciences Institutional Review Board 2010 - Present

Professional Memberships

Other Languages

  • Spanish, Chinese (Mandarin), Vietnamese, Portuguese, Thai, Chinese (Cantonese), Creole, Tamil, Croatian